| Value | ₹4.66 Cr |
|---|---|
| Execution period | 5 years |
NSE filing, NSE: VIPIND. Summary written from the filing by ALFA Finder's alert engine.
VIP Industries Ltd: key numbers
- Share price
- ₹251.75
- Market cap
- ₹3,576 Cr
- Revenue (annual)
- ₹1,858 Cr
- Net profit (annual)
- ₹-338.0 Cr
- P/E (TTM)
- -9.4×Sector 49.0×
- Promoter holding
- 42.35%+0.00% QoQ
- FII holding
- 4.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from VIP Industries Ltd
All →VIP Industries Other Announcement
VIP Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing constitutes routine regulatory compliance with no material business events.
VIP Industries Employee Stock Options
VIP Industries allotted 1,695 equity shares upon exercise of ESAR under its 2018 plan. The equity base rose to 14,20,55,391 shares, confirming routine employee incentive activity.
VIP Industries Fund Raise of ₹500 Cr
VIP Industries Ltd's board approved a fund raise of up to ₹500 Crore for FY 2026-27. The capital will support growth initiatives and working capital requirements.
- Value
- ₹500.0 Cr
VIP Industries Board Meeting Date
V.I.P. Industries will hold a board meeting on September 18, 2026, to evaluate fund-raising proposals through equity, debt, or other financial instruments.
VIP Industries Other Announcement
VIP Industries has filed its quarterly shareholding pattern for the period ending December 31, 2025.
VIP Industries Annual General Meeting
VIP Industries held its 59th Annual General Meeting on August 21, 2026, via video conferencing to transact business as per the notice.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date